BioForce Nanosciences Holdings, Inc.
BFNH
$1.79
$0.010.56%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.30K | 800.00 | 800.00 | 900.00 | 13.80K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.30K | 800.00 | 800.00 | 900.00 | 13.80K |
|
|
|||||
| Total Current Assets | 6.30K | 800.00 | 800.00 | 900.00 | 13.80K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.30K | 800.00 | 800.00 | 900.00 | 13.80K |
|
|
|||||
| Total Accounts Payable | 20.10K | 11.80K | 10.70K | 10.50K | 21.30K |
| Total Accrued Expenses | 607.50K | 506.20K | 421.80K | 317.20K | 211.50K |
| Short-term Debt | 99.80K | 101.30K | 68.20K | 57.20K | 42.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 727.30K | 619.30K | 500.70K | 384.90K | 275.00K |
|
|
|||||
| Total Current Liabilities | 727.30K | 619.30K | 500.70K | 384.90K | 275.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 99.80K | 101.30K | 68.20K | 57.20K | 42.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 727.30K | 619.30K | 500.70K | 384.90K | 275.00K |
|
|
|||||
| Common Stock & APIC | 161.79M | 161.79M | 161.79M | 161.79M | 161.79M |
| Retained Earnings | -162.51M | -162.41M | -162.29M | -162.18M | -162.05M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -721.00K | -618.50K | -499.90K | -384.00K | -261.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -721.00K | -618.50K | -499.90K | -384.00K | -261.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -721.00K | -618.50K | -499.90K | -384.00K | -261.20K |
|
|
|||||